Hanson Wade

R&D
6th Cytokine-Based Drug Development Summit 2025 banner
Partner Content

6th Cytokine-Based Drug Development Summit 2025

With more cytokine-based drugs entering clinical trials and novel combination and masking technologies being used, there is a growing need for experts to discuss, understand, and build on t

R&D
7th Treg-Directed Therapies Summit banner
Partner Content

7th Treg-Directed Therapies Summit

Unravelling Treg Biology, Pioneering Best-in-Class Approaches & Demonstrating Clinical Efficacy to Advance Validated Therapeutic Options in Autoimmunity, Inflammation & Beyond

R&D
2nd Peptide-Based Therapeutics Summit banner
Partner Content

2nd Peptide-Based Therapeutics Summit

With Merck’s oral PCSK9 inhibitor demonstrating strong phase 3 trial results, J&J’s IL23R antagonist peptide continuing its phase 3 journey, and Chugai advancing peptides into the intracellular